Valerie Barnett Cytek Biosciences, Inc. (CTKB) insider trading activity

CTKB Quotes by TradingView

Valerie Barnett is CHIEF LEGAL OFFICER of Cytek Biosciences, Inc.. Currently has a direct ownership of 42,044 shares of CTKB, which is worth approximately $234,605. The most recent transaction as insider was on May 20, 2024, when has been sold 3,751 shares (Common Stock) at a price of $5.96 per share, resulting in proceeds of $22,355. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42K
16.24% 3M change
82.25% 12M change
Total Value Held $234,605

Valerie Barnett Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2024
SELL
Payment of exercise price or tax liability
$22,355 $5.96 p/Share
3,751 Reduced 8.19%
42,044 Common Stock
May 20 2024
BUY
Exercise of conversion of derivative security
-
9,626 Added 17.93%
44,053 Common Stock
Mar 11 2024
SELL
Payment of exercise price or tax liability
$13,804 $7.22 p/Share
1,912 Reduced 5.02%
36,169 Common Stock
Mar 11 2024
BUY
Exercise of conversion of derivative security
-
4,908 Added 11.42%
38,081 Common Stock
Feb 20 2024
SELL
Payment of exercise price or tax liability
$6,586 $8.38 p/Share
786 Reduced 2.31%
33,173 Common Stock
Feb 20 2024
BUY
Exercise of conversion of derivative security
-
2,016 Added 5.6%
33,959 Common Stock
Nov 18 2023
SELL
Payment of exercise price or tax liability
$13,275 $5.98 p/Share
2,220 Reduced 6.5%
31,943 Common Stock
Nov 18 2023
BUY
Exercise of conversion of derivative security
-
5,697 Added 14.58%
33,377 Common Stock
Aug 18 2023
SELL
Payment of exercise price or tax liability
$18,781 $8.46 p/Share
2,220 Reduced 7.23%
28,466 Common Stock
Aug 18 2023
BUY
Exercise of conversion of derivative security
-
5,697 Added 16.0%
29,900 Common Stock
May 18 2023
SELL
Payment of exercise price or tax liability
$11,653 $6.69 p/Share
1,742 Reduced 7.02%
23,070 Common Stock
May 18 2023
BUY
Exercise of conversion of derivative security
-
4,470 Added 15.69%
24,026 Common Stock
Feb 21 2023
SELL
Payment of exercise price or tax liability
$8,622 $10.97 p/Share
786 Reduced 3.72%
20,342 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
-
2,016 Added 8.71%
21,128 Common Stock
Nov 18 2022
SELL
Payment of exercise price or tax liability
$11,593 $14.75 p/Share
786 Reduced 3.95%
19,111 Common Stock
Nov 18 2022
BUY
Exercise of conversion of derivative security
-
2,016 Added 9.2%
19,897 Common Stock
Aug 18 2022
SELL
Payment of exercise price or tax liability
$11,051 $14.06 p/Share
786 Reduced 4.21%
17,881 Common Stock
Aug 18 2022
BUY
Exercise of conversion of derivative security
-
2,016 Added 9.75%
18,667 Common Stock
May 18 2022
SELL
Payment of exercise price or tax liability
$10,104 $9.65 p/Share
1,047 Reduced 6.94%
14,041 Common Stock
May 18 2022
BUY
Exercise of conversion of derivative security
-
2,688 Added 15.12%
15,088 Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
$49,455 $4.71 p/Share
10,500 Added 45.85%
12,400 Common Stock
Jul 22 2021
BUY
Open market or private purchase
$32,300 $17.0 p/Share
1,900 Added 50.0%
1,900 Common Stock
VB

Valerie Barnett

CHIEF LEGAL OFFICER
Fremont, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTKB